Keywords:
Abdomen, Gastrointestinal tract, Liver, CT, CT-Quantitative, Diagnostic procedure, Contrast agent-other, Cirrhosis, Image verification
Authors:
Y. Inokuchi, S. Koya, M. Uematsu, T. Takashina ; Tokyo/JP
DOI:
10.26044/ecr2019/C-1055
Aims and objectives
Development of esophageal varices is the major complication of liver cirrhosis (LC),
bleeding from varices is most serious and life-threatening complication of LC [1-4].
Therefore,
all LC patients should undergo endoscopic screening for varices at diagnosis.
Endoscopic require that patients repeatedly undergo an unpleasant procedure.
However,
endoscopy should be repeated with or without varices at a few years later.
We presented at EPOS (C-1125) of ECR 2018 that the severity of portal hypertension with LC can be estimated by measuring the attenuation value obtained by subtracting CT value on the equilibrium phase from those on the portal phase at hepatic parenchyma of abdominal contrast enhanced dynamic multi-detector-row computed tomography (ACED-MDCT).
This exhibit is presented based on the increase of blood flow resistance accompanying the severity of hepatic fibrosis [4-9] and the hemodynamics of Iodine contrast material in internal body [10].
Therefore,
the aim of this study to investigate whether the attenuation value obtained by subtracting CT value on equilibrium phase from those on portal phase in the hepatic parenchyma at ACED-MDCT was useful as a predictor of esophageal varices (EVs) in patients with LC.